In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS IG considers service of monetary value to be remuneration, IG branch chief McAnaney warns.

Executive Summary

HHS IG CONSIDERS SERVICE OF MONETARY VALUE AS REMUNERATION, OIG Industry Guidance Branch Chief Kevin McAnaney warned at the May 20 Food and Drug Law Institute conference in Washington, D.C. The OIG considers any gift of service from a manufacturer a prosecutable action "regardless of what the services are. If they have monetary value, then they are classified as remuneration," McAnaney said. "If a supplier or manufacturer is basically providing that service to them, at no cost to them, we think that is double-dipping, and that is basically a discount."

Latest Headlines
See All
UsernamePublicRestriction

Register

PS030253

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel